Jubilant Gets FDA Nod for Generic Diuretic Medicine

by Kathy Jones on April 28, 2014 at 6:15 PM
 Jubilant Gets FDA Nod for Generic Diuretic Medicine

Jubilant Life Sciences announced on Friday that it has received approval from the US Food and Drugs Administration (FDA) to market a generic diuretic medicine.

The company has received abbreviated new drug application approval to market Spironolactone tablets (25 mg, 50 mg and 100 mg). These tablets are the generic version of GD Searle's Aldactone. Spironolactone is used to treat fluid retention caused by conditions such as congestive heart failure and cirrhosis of the liver.


Jubilant said in a press release that it will launch the drug in the first quarter of the fiscal year 2015-16. The market size of this diuretic is estimated to be $87 million per year.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Corporate News

 Global Report of Work-related Diseases
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
New AI Tool Could Ensure Smooth Job Transitions
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
 Recent Improvements In Pharmaceutical Sector
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Food to be Covered by Insurance Soon
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharma Companies Have to Support or Risk Damaging Global Reputation
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Jubilant Gets FDA Nod for Generic Diuretic Medicine Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests